The rationale for accepting elevated CO2. In patients with obstructive lung disease and ARDS, the ventilator settings required to normalize PaCO2 can cause ventilator-induced lung injury. Permissive hypercapnia — deliberately accepting elevated PaCO2 to allow lower, safer ventilator settings — is a validated lung-protective strategy when the clinical context is right. A pH above 7.20 is generally tolerated in permissive hypercapnia protocols.
When it is appropriate. Severe ARDS where lung-protective tidal volumes produce rising CO2 — accept hypercapnia rather than increase tidal volume. Status asthmaticus with severe gas trapping — accept hypercapnia to reduce I:E ratio and allow adequate exhalation. The target is not normal CO2 but avoiding lung injury.
When it is actively dangerous. Pulmonary hypertension — hypercapnia causes pulmonary vasoconstriction and increases RV afterload. Elevated intracranial pressure — hypercapnia causes cerebral vasodilation and increases ICP. Severe metabolic alkalosis — adding respiratory acidosis can produce paradoxical acidosis. These three contraindications are not always flagged in protocols that allow permissive hypercapnia.
Practical bedside rule: Before accepting permissive hypercapnia, ask: (1) Does this patient have pulmonary hypertension? (2) Is ICP a concern? (3) Is there a metabolic alkalosis that will be worsened by respiratory acidosis? If any of these are yes, permissive hypercapnia requires explicit team discussion rather than automatic protocol application.
Why pediatric NIV is different from adult practice. Interface fitting is the primary challenge. Children have smaller, more variable facial anatomy, making mask fit far more critical and technically demanding. A poorly fitted mask causes air leak, reduces delivered pressure, increases work of breathing, and causes skin breakdown faster than in adults. The RT selecting and fitting the interface for a pediatric NIV patient is making a clinical decision that determines whether the treatment works.
Neonatal non-invasive respiratory support. In neonates, the spectrum includes bubble CPAP, nasal CPAP, HFNC, nasal IMV (NIMV), and nasal CPAP with pressure support. Bubble CPAP — most commonly used in NICUs for premature infants with RDS — generates CPAP through submersion of the expiratory limb in water, producing gentle oscillation that may provide additional benefit beyond static CPAP. The RT monitors water level, prong position, clinical response, and escalation indicators.
Pressure settings in children. Pediatric BiPAP settings are typically lower than adult settings: IPAP starting at 8 to 10 cmH2O, EPAP at 4 to 5 cmH2O, with titration based on clinical response and tidal volume delivery. Lungs of a child with normal compliance will fill quickly with pressures inadequate for an adult with reduced compliance — starting settings are lower and titration increments are smaller.
For adult-trained RTs who encounter pediatric NIV: The principles are the same but the execution is different. Interface fitting, pressure targets, and escalation thresholds differ enough that adult autopilot settings are inappropriate. If your facility has mixed-age units or transfers pediatric patients, request dedicated pediatric NIV training before it is urgently needed.
What the test measures. Bronchodilator responsiveness testing is performed by administering a short-acting bronchodilator (typically albuterol 400 mcg via MDI with spacer) and repeating spirometry 15 to 20 minutes later. A significant response is defined by the ATS/ERS as an improvement of at least 12 percent and 200 mL in FEV1 or FVC. The test distinguishes fixed from partially reversible airflow obstruction and informs both diagnosis and treatment selection.
What a positive response means — and what it does not. A significant response confirms reversible airflow obstruction, supporting an asthma diagnosis. Importantly, a negative response does not rule out asthma — asthma is a variable condition and the test is performed on a single day. A patient with asthma tested on a low-symptom day may show no response. A negative response in a patient with fixed obstructive pattern more strongly suggests COPD or another fixed obstructive condition.
The quality control dimension. Bronchodilator responsiveness results are only meaningful if the pre-bronchodilator spirometry meets ATS acceptability and reproducibility criteria. An RT who administers the test without ensuring adequate pre-bronchodilator effort quality will generate a result that cannot be interpreted. The three-trial minimum, acceptability criteria, and reproducibility criteria apply before the bronchodilator is given.
Why RT interpretation matters: In many pulmonary clinics, the RT result report goes directly to the physician chart. A well-constructed RT interpretation that flags quality limitations, correctly identifies a significant response, and contextualizes the clinical significance is documentation that directly influences diagnostic and treatment decisions.
What a clinical ladder is. A formal, structured program defining levels of clinical practice and professional achievement — typically three to four tiers from entry-level staff RT to senior clinical specialist — with explicit criteria for advancement, associated compensation increases, and documented expectations at each level. It gives RTs a defined pathway for professional growth within their current department rather than having to change jobs or move into management to advance.
Why most RT departments do not have one. Clinical ladders require upfront administrative investment that many departments have not prioritized. The result: RT departments with flat compensation structures where a 15-year ICU specialist and a two-year graduate earn the same base rate. This is a retention disaster in a profession with a documented workforce shortage.
What a clinical ladder typically includes. Level 1 (Staff RT): RRT credential, competency completion, basic unit independence. Level 2 (Senior RT): 2 to 3 years experience, specialty CE, charge experience. Level 3 (Clinical Specialist): specialty credential (NPS, ACCS, RPSGT), outcomes contribution, protocol development. Level 4 (Clinical Expert/Lead): department-level program ownership, peer and institutional recognition. Each tier has a defined compensation premium — typically 3 to 8 percent above the previous level.
If you are a staff RT at a facility without a ladder: Build your own. Document your clinical activities, outcomes, and professional contributions at the level of a clinical specialist even if the formal title and compensation do not exist yet. When the ladder is implemented — or when you apply elsewhere — you will have the evidence base already constructed.
Next: AARC Congress 2026 recap — what was announced in New Orleans and what it means for RT practice in 2027.
Soon: Neonatal transport RT — the credential pathway and what the career looks like from practitioners doing it.
On deck: RT advocacy in 2027 — the legislative landscape heading into the new Congressional session.
Staying at the vent,
15 years across academic medical centers & community hospitals
